BACKGROUND: Long-QT syndrome (LQTS) is characterized by such striking clinical heterogeneity that, even among family members carrying the same mutation, clinical outcome can range between sudden death and no symptoms. We investigated the role of genetic variants as modifiers of risk for cardiac events in patients with LQTS. METHODS AND RESULTS: In a matched case-control study including 112 patient duos with LQTS from France, Italy, and Japan, 25 polymorphisms were genotyped based on either their association with QTc duration in healthy populations or on their role in adrenergic responses. The duos were composed of 2 relatives harboring the same heterozygous KCNQ1 or KCNH2 mutation: 1 with cardiac events and 1 asymptomatic and untreated. The findings were then validated in 2 independent founder populations totaling 174 symptomatic and 162 asymptomatic patients with LQTS, and a meta-analysis was performed. The KCNQ1 rs2074238 T-allele was significantly associated with a decreased risk of symptoms 0.34 (0.19-0.61; P<0.0002) and with shorter QTc (P<0.0001) in the combined discovery and replication cohorts. CONCLUSIONS: We provide evidence that the KCNQ1 rs2074238 polymorphism is an independent risk modifier with the minor T-allele conferring protection against cardiac events in patients with LQTS. This finding is a step toward a novel approach for risk stratification in patients with LQTS.
BACKGROUND:Long-QT syndrome (LQTS) is characterized by such striking clinical heterogeneity that, even among family members carrying the same mutation, clinical outcome can range between sudden death and no symptoms. We investigated the role of genetic variants as modifiers of risk for cardiac events in patients with LQTS. METHODS AND RESULTS: In a matched case-control study including 112 patient duos with LQTS from France, Italy, and Japan, 25 polymorphisms were genotyped based on either their association with QTc duration in healthy populations or on their role in adrenergic responses. The duos were composed of 2 relatives harboring the same heterozygous KCNQ1 or KCNH2 mutation: 1 with cardiac events and 1 asymptomatic and untreated. The findings were then validated in 2 independent founder populations totaling 174 symptomatic and 162 asymptomatic patients with LQTS, and a meta-analysis was performed. The KCNQ1 rs2074238 T-allele was significantly associated with a decreased risk of symptoms 0.34 (0.19-0.61; P<0.0002) and with shorter QTc (P<0.0001) in the combined discovery and replication cohorts. CONCLUSIONS: We provide evidence that the KCNQ1 rs2074238 polymorphism is an independent risk modifier with the minor T-allele conferring protection against cardiac events in patients with LQTS. This finding is a step toward a novel approach for risk stratification in patients with LQTS.
Entities:
Keywords:
association studies; genetics; ion channel; long-QT syndrome; polymorphism; risk factor
Authors: Marta Tomás; Carlo Napolitano; Luciana De Giuli; Raffaella Bloise; Isaac Subirana; Alberto Malovini; Riccardo Bellazzi; Dan E Arking; Eduardo Marban; Aravinda Chakravarti; Peter M Spooner; Silvia G Priori Journal: J Am Coll Cardiol Date: 2010-06-15 Impact factor: 24.094
Authors: Peter A Noseworthy; Aki S Havulinna; Kimmo Porthan; Annukka M Lahtinen; Antti Jula; Pekka J Karhunen; Markus Perola; Lasse Oikarinen; Kimmo K Kontula; Veikko Salomaa; Christopher Newton-Cheh Journal: Circ Cardiovasc Genet Date: 2011-04-21
Authors: Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker Journal: Bioinformatics Date: 2008-10-30 Impact factor: 6.937
Authors: P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise Journal: Circulation Date: 2001-01-02 Impact factor: 29.690
Authors: Peter J Schwartz; Emilio Vanoli; Lia Crotti; Carla Spazzolini; Chiara Ferrandi; Althea Goosen; Paula Hedley; Marshall Heradien; Sara Bacchini; Annalisa Turco; Maria Teresa La Rovere; Antonella Bartoli; Alfred L George; Paul A Brink Journal: J Am Coll Cardiol Date: 2008-03-04 Impact factor: 24.094
Authors: Ludmila Pawlikowska; Jeffrey Nelson; Diana E Guo; Charles E McCulloch; Michael T Lawton; William L Young; Helen Kim; Marie E Faughnan Journal: Am J Med Genet A Date: 2015-04-02 Impact factor: 2.802
Authors: Alberto Porta; Giulia Girardengo; Vlasta Bari; Alfred L George; Paul A Brink; Althea Goosen; Lia Crotti; Peter J Schwartz Journal: J Am Coll Cardiol Date: 2015-02-03 Impact factor: 24.094
Authors: Iris C R M Kolder; Michael W T Tanck; Pieter G Postema; Jean-Jacques Schott; Eric Schulze-Bahr; Connie R Bezzina; Julien Barc; Moritz F Sinner; Sven Zumhagen; Anja Husemann; Birgit Stallmeyer; Tamara T Koopmann; Nynke Hofman; Arne Pfeufer; Peter Lichtner; Thomas Meitinger; Britt M Beckmann; Robert J Myerburg; Nanette H Bishopric; Dan M Roden; Stefan Kääb; Arthur A M Wilde Journal: Circ Cardiovasc Genet Date: 2015-03-03
Authors: James R Priest; Scott R Ceresnak; Frederick E Dewey; Lindsey E Malloy-Walton; Kyla Dunn; Megan E Grove; Marco V Perez; Katsuhide Maeda; Anne M Dubin; Euan A Ashley Journal: Heart Rhythm Date: 2014-06-25 Impact factor: 6.343